The Journal of Clinical and Translational Immunology (JCTI) is committed to upholding the highest standards of scholarly publishing. Our editorial policies are designed to ensure fairness, transparency, and integrity throughout the editorial and peer review process.

1. Editorial Independence

• The editorial team operates independently of commercial, institutional, or political influence.
• Editorial decisions are based solely on the scientific validity, originality, and significance of submitted work.
• Sponsors or advertisers have no role in manuscript evaluation or acceptance.

2. Peer Review Model

• JCTI follows a double-blind peer review process, where the identities of authors and reviewers are concealed.
• At least two independent expert reviewers evaluate each manuscript.
• Final editorial decisions are made by the Editor-in-Chief, with input from handling editors when required.

3. Criteria for Publication

Manuscripts must meet the following criteria to be considered for publication:

• Originality and novelty of the research.
• Scientific rigor and methodological soundness.
• Clear and logical presentation of results.
• Contribution to the advancement of immunology and its clinical applications.
• Ethical compliance in human and animal research.

4. Ethical Standards

• JCTI adheres to the guidelines of the Committee on Publication Ethics (COPE).
• Authors must declare approval from an Institutional Review Board (IRB) or Ethics Committee for studies involving human participants.
• Animal studies must comply with national and institutional regulations.
• Informed consent is required for patient data, images, and case reports.

5. Conflicts of Interest

• Authors, reviewers, and editors must disclose any financial, professional, or personal conflicts of interest that may influence their work.
• Conflicts are assessed by the editorial office and managed transparently to preserve objectivity.

6. Authorship and Contribution

• Authorship should reflect substantial intellectual contribution to the conception, design, execution, or interpretation of the research.
• All authors must approve the final manuscript before submission.
• Guest, honorary, or ghost authorship is not permitted.

7. Plagiarism and Research Misconduct

• Plagiarism, data fabrication, falsification, duplicate submission, or image manipulation are strictly prohibited.
• All manuscripts are subject to plagiarism screening.
• Cases of misconduct will be investigated and may result in rejection, retraction, or reporting to relevant institutions.

8. Open Access Policy

• JCTI is an open access journal, ensuring that all published content is freely accessible worldwide without subscription barriers.
• Articles are published under the Creative Commons Attribution (CC BY) License, allowing unrestricted use, distribution, and reproduction with proper citation.

9. Appeals and Complaints

• Authors may appeal editorial decisions by submitting a reasoned request to the Editor-in-Chief.
• Complaints regarding peer review, editorial handling, or publication ethics will be investigated in line with COPE guidance.

10. Transparency and Accountability

• The journal is committed to timely communication with authors and reviewers.
• All editorial processes are conducted with fairness, impartiality, and confidentiality.
• Corrections, errata, or retractions will be published when necessary to maintain the scientific record.